Alternatives
Alternatives to Egrifta WR kit
There are 1 alternatives to this medicine in the catalogue: the same active ingredient (Tesamorelin), strength () and dosage form (kit) from 1 other makers or registers. The table compares packs, storage, lead time, documents and availability.
Side by side
The first row is the medicine you came from.
| Medicine | Manufacturer | Register | Packs | Storage | Lead time | Documents | Availability |
|---|---|---|---|---|---|---|---|
| Egrifta WR kitThis pageSubcutaneous | Theratechnologies | US FDA | 1 kit | Do not freeze. Store EGRIFTA WR 11.6 mg vial at room temperature at 20°C to 25°C (68°F to 77°F) in the original box to protect from light, excursions permitted to 15°C to 30°C (59°F to 86°F). Store the Injection box (containing Bacteriostatic Water for Injection, syringes, needles and alcohol swabs) at room temperature at 20°C to 25°C (68°F to 77°F). | On request | — | Available on request |
| Egrifta SV kitSubcutaneous | Theratechnologies | US FDA | 1 kit | Store EGRIFTA SV 2 mg vial at room temperature at 20°C to 25°C (68°F to 77°F), excursions permitted to 15°C to 30°C (59°F to 86°F). Store the Injection box (containing Sterile Water for Injection, syringes and needles) at room temperature at 20°C to 25°C (68°F to 77°F). | On request | — | Available on request |
This is a biological medicine. Products from other makers are biosimilars, not identical copies, and switching between them follows the prescriber's and regulator's rules.
Alternatives are listed for sourcing. Whether one medicine can replace another is the prescriber's decision, under the rules of the destination country.
For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Back to Egrifta WR kitNot sure which maker to choose?
Request a quote for the medicine and we will propose the options that fit your country's import rules and timelines.